Stock listing

Helsinki:HRTIS Herantis Pharma PLC Osake

Home listing (Helsinki) of Herantis Pharma PLC

Follow Herantis Pharma PLC into a list and get an email when it puts out news.

Share price · OMXHEX:HRTIS

€1.18 EUR -0.02 (-1.7%)

Close on Oct 30, 2026

Past year -47.1% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
€1.12 – €1.20 EUROct 30, 2026
Volume
64,380 sharesOct 30, 2026
Market cap
€31.27M EURAt the close on Oct 30, 2026 · price × 26.50M shares outstanding
52-week range
€1.12 – €2.87 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
€44,773 EURMedian day 24,134 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Herantis Pharma PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Helsinki:HRTIS · Home€1.18 EUR-0.02 (-1.7%)64,380€1.20€1.20€1.118€1.20Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OMXHEX:HRTIS · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.18-0.02-1.7%€1.20€1.20€1.11864,380
€1.20-0.034-2.8%€1.29€1.29€1.1727,832
€1.234-0.046-3.6%€1.26€1.26€1.23411,527
€1.28+0.114+9.8%€1.158€1.28€1.15841,785
€1.166+0.016+1.4%€1.138€1.174€1.1399,545
€1.15-0.076-6.2%€1.25€1.25€1.13250,997
€1.226-0.024-1.9%€1.248€1.248€1.2119,388
€1.25-0.016-1.3%€1.268€1.27€1.2513,091
€1.266-0.014-1.1%€1.33€1.33€1.2519,683
€1.28-0.016-1.2%€1.36€1.36€1.2714,249
€1.296-0.002-0.2%€1.296€1.298€1.2721,910
€1.298-0.062-4.6%€1.358€1.358€1.27437,796
€1.36+0.014+1.0%€1.36€1.37€1.34211,360
€1.346-0.016-1.2%€1.362€1.37€1.31634,236
€1.362+0.02+1.5%€1.342€1.362€1.33829,786
€1.342+0.004+0.3%€1.35€1.362€1.32812,773
€1.338-0.006-0.4%€1.42€1.42€1.3311,667
€1.344-0.056-4.0%€1.41€1.42€1.34411,859
€1.40+0.03+2.2%€1.372€1.40€1.34229,524
€1.37-0.048-3.4%€1.36€1.37€1.3241,046
€1.418+0.026+1.9%€1.392€1.428€1.34216,567
€1.392-0.03-2.1%€1.422€1.422€1.35819,043
€1.422+0.016+1.1%€1.38€1.428€1.3713,202
€1.406-0.02-1.4%€1.45€1.45€1.38211,750
€1.426+0.026+1.9%€1.40€1.448€1.37224,626
€1.400.000.0%€1.398€1.422€1.35426,860
€1.40+0.008+0.6%€1.398€1.40€1.3521,722
€1.392-0.008-0.6%€1.40€1.40€1.37221,941
€1.40+0.01+0.7%€1.404€1.41€1.3947,175
€1.39-0.01-0.7%€1.40€1.416€1.38418,696
€1.40+0.012+0.9%€1.392€1.41€1.3848,462
€1.388-0.022-1.6%€1.412€1.428€1.38434,905
€1.410.000.0%€1.412€1.412€1.3818,974
€1.41-0.02-1.4%€1.43€1.43€1.4060,102
€1.43-0.038-2.6%€1.458€1.462€1.42232,111
€1.468-0.01-0.7%€1.51€1.51€1.45414,196
€1.478-0.022-1.5%€1.50€1.522€1.45631,157
€1.50-0.03-2.0%€1.53€1.544€1.4660,971
€1.53-0.03-1.9%€1.56€1.582€1.52425,220
€1.56-0.036-2.3%€1.596€1.596€1.5426,407
€1.596+0.036+2.3%€1.56€1.598€1.5466,903
€1.56-0.002-0.1%€1.564€1.59€1.54212,308
€1.562-0.026-1.6%€1.57€1.586€1.5419,023
€1.588-0.048-2.9%€1.618€1.634€1.55413,973
€1.636-0.014-0.8%€1.65€1.66€1.62211,966
€1.65+0.03+1.9%€1.658€1.696€1.64820,408
€1.620.000.0%€1.638€1.68€1.6212,313
€1.62-0.07-4.1%€1.66€1.682€1.60624,590
€1.69+0.052+3.2%€1.652€1.69€1.65210,781
€1.638+0.106+6.9%€1.56€1.64€1.5627,497
€1.532+0.002+0.1%€1.592€1.626€1.53266,285
€1.53-0.16-9.5%€1.678€1.678€1.52687,493
€1.69-0.02-1.2%€1.702€1.708€1.65417,272
€1.71-0.068-3.8%€1.78€1.786€1.69424,609
€1.778-0.008-0.4%€1.78€1.786€1.72216,648
€1.786+0.026+1.5%€1.772€1.85€1.76248,372
€1.76+0.108+6.5%€1.68€1.762€1.689,067
€1.652-0.018-1.1%€1.692€1.716€1.6524,624
€1.67-0.042-2.5%€1.758€1.758€1.6438,294
€1.712+0.082+5.0%€1.652€1.792€1.652116,690
€1.63+0.07+4.5%€1.60€1.706€1.60118,566
€1.56+0.048+3.2%€1.558€1.606€1.5565,995
€1.512-0.036-2.3%€1.486€1.53€1.4420,591
€1.548-0.002-0.1%€1.552€1.56€1.5129,915
€1.55-0.01-0.6%€1.562€1.58€1.5024,134
€1.56+0.02+1.3%€1.54€1.632€1.50625,887
€1.54-0.048-3.0%€1.65€1.65€1.5332,531
Ticker
Helsinki:HRTIS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Helsinki
Currency
EUR

What changed lately

Latest news

Herantis Pharma Oyj to publish financial statements for the first half of 2026 on August 20, 2026 – invitation to webcast presentation

Aug 10, 2026

Closed €1.71 (+5.0%) on Aug 10, 2026

Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer

Jun 25, 2026

Closed €1.87 (+0.2%) on Jun 25, 2026

Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096

Jun 2, 2026

Closed €2.27 (+2.0%) on Jun 2, 2026

Plc Annual Report 2025

Mar 30, 2026

Closed €1.62 (-2.1%) on Mar 30, 2026

Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases

Mar 16, 2026

Closed €1.90 (+2.7%) on Mar 16, 2026

Herantis Pharma releases 2H and FY 2025 report today

Mar 5, 2026

Closed €2.03 (-2.4%) on Mar 5, 2026

Herantis Pharma Oyj to publish financial statements 2025 on 5 March 2026 – invitation to webcast presentation

Feb 23, 2026

Closed €2.15 (-0.5%) on Feb 23, 2026

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Feb 19, 2026

Closed €2.16 (-0.5%) on Feb 20, 2026

Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease

Jan 7, 2026

Closed €2.55 (+5.8%) on Jan 8, 2026

Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096

Nov 26, 2025

Closed €2.17 (+2.4%) on Nov 26, 2025

All Herantis Pharma PLC news

Decks

Herantis Pharma PLC on 6ix

Sector
Health care
Industry
Biotechnology
News releases
11 in the last 12 months · 17 in all · newest Aug 10, 2026 · oldest 2025
Decks
13 decks · latest September 2026

Where Herantis Pharma PLC is listed

ListingExchangeCountryCurrency
Helsinki:HRTIS · Home listing · This pageHelsinkiFinlandEUR
LS Exchange:A1158VLS ExchangeGermanyEUR
Lang & Schwarz:A1158VLang & SchwarzGermanyEUR

Log in to ask 6ix AI your own questions about Herantis Pharma PLC.